OAM
IDIX

Oxford Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Oxford Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-686,376
Closed -$16.6M – 858
2014
Q2 		$16.6M Sell
686,376
-15,405
-2% -$161K 0.54% 24
2014
Q1 		$4.23M Buy
+701,781
New +$4.89M 0.12% 249

Oxford Asset Management's IDIX Position: Q3 2014 in Review

Oxford Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 686,376 shares — an estimated $16.6M sold.

Oxford Asset Management first reported a position in IDIX in Q1 2014 and held it in 2 quarters. The position peaked at $16.6M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Oxford Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Oxford Asset Management sold 686,376 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $16.6M.
  • Oxford Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q1 2014 and held it in 2 quarters.
  • Oxford Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $16.6M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Oxford Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.